tiprankstipranks
Trending News
More News >

Ali Behbahani Insider Profile

4 Followers
Ali Behbahani, Director at Nevro Corp, holds 0.00 shares in NeueHealth Inc (Ticker: NEUE), holds 4.53M shares in Black Diamond Therapeutics (Ticker: BDTX), holds 0.00 shares in Adaptimmune Therapeutics (Ticker: ADAP).
tipranks
Ali Behbahani

Ali Behbahani
Nevro Corp (NVRO)
Director

Ranked #100,223 out of 104,058 Corporate Insiders

Profitable Transactions

19%
4 out of 21 Profitable Transactions

Average Return

-36.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$557M
28.89%
21.17%
15.87%
13.89%
20.19% Others
A breakdown of Ali Behbahani's holdings

Insider Roles

Mirum Pharmaceuticals
(MIRM)
Ten Percent Owner
Trevi Therapeutics
(TRVI)
Ten Percent Owner
Savara
(SVRA)
Ten Percent Owner
Monte Rosa Therapeutics
(GLUE)
Director, Ten Percent Owner
+10 other positions
Roles that Ali Behbahani holds in companies

Most Profitable Insider Trade

Stock:
Mirum Pharmaceuticals
(MIRM)
Rating:Informative Buy
Date:Jul 24, 2019 - Jul 24, 2020
Return:+47.80%
The most profitable trade made by Ali Behbahani

Ali Behbahani's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
NVRO
Nevro Corp
May 23, 2018
Uninformative Buy
$31.48K
Adaptimmune Therapeutics
Aug 19, 2025
Director
Informative Sell
195.00K
$0.00
Genocea Biosciences
May 26, 2022
Director, Ten Percent Owner
Informative Sell
711.52K
Crispr Therapeutics AG
Aug 14, 2020
Director
Uninformative Buy
$18.67K
RGLS
Regulus
May 09, 2019
Informative Buy
1.23M
$16.75M
Trevi Therapeutics
Apr 13, 2022
Ten Percent Owner
Informative Buy
6.80M
$117.80M
Mirum Pharmaceuticals
Jun 15, 2023
Ten Percent Owner
Uninformative Buy
$160.76M
Black Diamond Therapeutics
Sep 22, 2025
Director
Uninformative Buy
14.37K
$18.17M
OYST
Oyster Point Pharma
Jan 04, 2023
Uninformative Sell
$0.00
AKUS
AKOUOS
Dec 02, 2022
Uninformative Sell
$0.00
Nkarta
Director
MTCR
Metacrine
Dec 27, 2021
Informative Sell
493.91K
$1.49M
Monte Rosa Therapeutics
Jun 30, 2021
Director, Ten Percent Owner
Uninformative Buy
$77.31M
CVRx
Dec 18, 2023
Director
Uninformative Buy
72.68
$3.14K
NEUE
NeueHealth Inc
Oct 06, 2025
Uninformative Buy
6.81K
$0.00
Minerva Surgical
Jun 14, 2022
Director
Uninformative Buy
120.00K
Arcellx Inc
Aug 14, 2025
Director
Uninformative Buy
$402.85K
Savara
Jul 19, 2023
Ten Percent Owner
Informative Buy
1000.00K
$88.34M
Korro Bio
Apr 24, 2024
Director, Ten Percent Owner
Uninformative Buy
999.99K
$45.98M
MBX Biosciences, Inc.
Sep 17, 2024
Ten Percent Owner
Uninformative Buy
$47.78M
List of latest transactions for each holding click on a transaction to see Ali Behbahani's performance on stock

Ali Behbahani insider profile FAQ

What is the percentage of profitable transactions made by Ali Behbahani?
The percentage of profitable transactions made by Ali Behbahani is 19%.
    What is the average return per transaction made by Ali Behbahani?
    The average return per transaction made by Ali Behbahani is -36.30%.
      What stocks does Ali Behbahani hold?
      Ali Behbahani holds: NVRO, ADAP, GNCAQ, CRSP, RGLS, TRVI, MIRM, BDTX, OYST, AKUS, NKTX, MTCR, GLUE, CVRX, NEUE, UTRS, ACLX, SVRA, KRRO, MBX stocks.
        What was Ali Behbahani’s latest transaction?
        Ali Behbahani latest transaction was an Uninformative Buy of $6.81K.
          What was Ali Behbahani's most profitable transaction?
          Ali Behbahani’s most profitable transaction was an Informative Buy of MIRM stock on July 24, 2019. The return on the trade was 47.80%.
            What is Ali Behbahani's role in Nevro Corp?
            Ali Behbahani's role in Nevro Corp is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.